FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

19503111000001102: Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66071501000001119 Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103954401000001116 Rapilose OGTT solution (Galen Ltd) 300 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml Is a Glucose 75g/300ml oral solution 300 ml true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml Has AMP Rapilose OGTT solution (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml Has specific active ingredient Glucose true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml Legal category Legal category not applicable true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rapilose OGTT solution (Aspire Pharma Ltd) 300 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start